Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
1.400
-0.010 (-0.71%)
At close: Nov 20, 2024, 4:00 PM
1.430
+0.030 (2.14%)
After-hours: Nov 20, 2024, 4:52 PM EST
Salarius Pharmaceuticals Market Cap
Salarius Pharmaceuticals has a market cap or net worth of $2.02 million as of November 21, 2024. Its market cap has decreased by -30.43% in one year.
Market Cap
2.02M
Enterprise Value
-937.56K
1-Year Change
-30.43%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since January 29, 2015, Salarius Pharmaceuticals's market cap has decreased from $254.40M to $2.02M, a decrease of -99.21%. That is a compound annual growth rate of -38.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 2.00M | -23.08% |
| Dec 29, 2023 | 2.60M | -25.71% |
| Dec 30, 2022 | 3.50M | -84.38% |
| Dec 31, 2021 | 22.40M | 23.76% |
| Dec 31, 2020 | 18.10M | 17.53% |
| Dec 31, 2019 | 15.40M | 156.67% |
| Dec 31, 2018 | 6.00M | -90.43% |
| Dec 29, 2017 | 62.70M | -33.93% |
| Dec 30, 2016 | 94.90M | -57.52% |
| Dec 31, 2015 | 223.40M | -12.19% |
| Jan 29, 2015 | 254.40M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 2.20M |
| Xylo Technologies | 2.16M |
| Qualigen Therapeutics | 2.09M |
| Biodexa Pharmaceuticals | 2.09M |
| Scorpius Holdings | 2.06M |
| GRI Bio | 2.01M |
| Akanda | 2.00M |
| Shuttle Pharmaceuticals Holdings | 1.98M |